APPENDIX A-Normal Values in Humans
APPENDIX A-Normal Values in Humans
Women
Test
Conventional Units
SI
Conventional Units
SI
Hemoglobin
14-17.4 g/dl
140-175 g/L
12.3-15.3 g/dl
123-153 g/L
Hematocrit (UPRC)
41.5-50.4
0.415-0.504
36-45
0.36-0.45
4.5-5.9106 /muL
4.5-5.91012 /L
4.5-5.1106 /muL
4.5-5.11012 /L
4.4-11.3103 /muL
4.4-11.3109 /L
4.4-11.3106 /muL
4.4-11.3109 /L
Mean corpuscular
volume
80-96 fL
80-96 fL
80-96 fL
80-96 fL
Mean corpuscular
hemoglobin
27.5-33.2 pg
27.5-33.2 pg
27.5-33.2 pg
27.5-33.2 pg
Mean corpuscular
hemoglobin
concentration
33.4-35.5 g/dL
334-355 g/L
33.4-35.5 g/dL
334-355 g/L
Platelet count
150-45010 /muL
150-45010 /L
150-45010 /muL
150-450109 /L
Reticulocyte count
0.5-2.5%
0.005-0.025
0.5-2.5%
0.005-0.025
Reticulocyte count
22,500147,500/mm3
22.5-147.5109 /L
22,500147,500/mm3
22.5-147.5109 /L
Sedimentation rate
(Westergren) less
than 50 years of age
0-15 mm/hr
0-15 mm/hr
0-20 mm/hr
0-20 mm/hr
Zeta sedimentation
rate
41-54
41-54
41-54
41-54
SI =Systeme Internationale.
Values derived from Wintrobe MM. Clinical hematology. 9th ed. Philadelphia: Lea & Febiger, 1993 (1).
Conventional Units
Women
SI
Conventional Units
SI
Henry JB. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: WB Saunders,
1996 (2). Beutler E, Lichtman MA, Coller BS, Kipps TJ. William's hematology. 5th ed. New York:
McGraw-Hill, 1995 (3).
2739
Mean
Central 95%
Range
Mean
Central 95%
Range
6.6
3.5-9.8
6.7
4.4-8.2
280
147-412
285
147-422
5.4
4.76-6.04
5.54
4.87-6.20
Hemoglobin (g/dL)
16.4
14.7-18.1
16.2
14.6-17.8
Hematocrit (%)
48.7
43.7-53.6
48.7
43.6-53.8
Mean corpuscular
volume (fL)
90.3
83.3-97.2
88.0
80.9-95.2
Mean corpuscular
hemoglobin (pg)
30.5
28.1-32.9
29.3
27.0-31.7
Mean corpuscular
hemoglobin
concentration (g/dL)
33.8
33.0-34.6
33.3
32.1-34.6
12.4
11.5-13.4
12.8
12.0-13.6
Mean platelet
volume
8.4
6.8-10.0
8.9
7.6-10.2
Data are based on measurements from healthy male medical students, age range 23-31 years at an altitude
of 4500 ft, January 1989.
Women
Test
Conventional Units
SI
Conventional Units
SI
Serum iron
60-150 mug/dL
10.7-26.9 mumol/L
60-150 mug/dL
10.7-26.9 mumol/L
Women
Test
Conventional Units
SI
Conventional Units
SI
250-435 mug/dL
44.8-77.7 mumol/L
250-435 mug/dL
44.8-77.7 mumol/L
Ferritin
15-200 ng/mL
15-200 ng/mL
12-150 ng/mL
12-150 ng/mL
Serum B12
160-950 pg/mL
118-701 pmol/L
160-950 pg/mL
118-701 pmol/L
Serum folate
2-25 ng/mL
4-56 nmol/L
2-25 ng/mL
4-56 nmol/L
140-640 ng/mL
550-1450 nmol/L
140-640 ng/mL
550-1450 nmol/L
Hemoglobin A2
1.5-3.5%
0.015-0.035
1.5-3.5%
0.015-0.035y
Hemoglobin F
<2%
<0.02
<2%
<0.02
Values derived from Wintrobe MM. Clinical hematology. 9th ed. Philadelphia: Lea & Febiger, 1993 (1).
Henry JB. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: WB Saunders,
1996 (2). Beutler E, Lichtman MA, Coller BS, Kipps TJ. William's hematology. 5th ed. New York:
McGraw-Hill, 1995 (3).
SI =Systeme Internationale.
TABLE A-4 -- Measures of Red Cell Concentration in Normal Adults at Sea Level
Men
Determination
Mean
95% Range
Mean
95% Range
Hematocytometer
(4)
5.4
4.5-6.3
4.8
4.2-5.5
Electronic (5)
5.2
4.4-6.0
--
--
Cyanmethemoglobin
(4)
16.0
14.0-18.0
14.0
12.0-16.0
0.47
0.40-0.54
0.42
0.37-0.47
Micro (5)
0.46
0.51-0.51
--
--
1.6
88
1.6
57.7
0.8-3.0 18-158
0.8-3.0 30.5101.2
1.6
88
1.6
46.8
0.8-3.0
18-158 0.8-3.0
22.0-94.0
Sedimentation Wintrobe or
rate (mm/hr) (8) Westergren
0-15
10
0-20
(%)
--
40-52
--
40-52
Erythrocytes
(1012 /L)
Hemoglobin
(g/dL)
Method
Women
Reticulocytes
New methylene blue
(6,7) % 109 /L Electronic
% 109 /L
Zeta sedimentation
rate
2740
Mean
95% Limits
RBC: Hemacytometer
VPRC: Macro (4)
87
80-94
90
83-97
85
77-93
88
80-96
RBC: Electronic
VPRC: Micro (9)
Mean corpuscular volume
(fL)
RBC: Hemacytometer
VPRC: Micro (5)
RBC: Electronic
VPRC: Micro (5)
Mean corpuscular
hemoglobin (pg/cell)
78.5-98
26-32
27-34
Mean corpuscular
hemoglobin concentration
(g/dL RBC)
VPRC: Macro
34
32-36
33
31-35
33.5-36
Meters
VPRC (L/L) M
721
0.47
4,400
1340
744
0.495
7,457
2280
100
0.51
12,240
3740
40
0.54
14,900
4540
32
0.61
17,800
5430
10
0.69
TABLE A-7 -- Effect of Pregnancy, With and Without Iron Supplementation, on Values for Volume Packed
Red Cells (VPRC) and Hemoglobin (Hb) (11)
VPRC (Mean, L/L)
Hb (Mean, g/dL)
Intramuscular
Oral
Supplement Supplement
No
Supplement
Intramuscular
Oral
Supplement Supplement
Weeks of
Gestation
No
Supplement
0.420
--
--
13.4
--
--
12
0.383
0.406
0.357
12.5
13.1
11.4
16
0.395
0.379
0.363
12.4
12.1
11.4
20
0.364
0.370
0.371
11.7
11.8
11.8
24
0.356
0.363
0.371
11.4
11.8
11.8
28
0.346
0.369
0.368
11.0
11.8
11.8
32
0.341
0.372
0.370
10.6
12.1
11.8
36
0.343
0.375
0.375
10.7
12.1
12.0
40
0.349
0.385
0.387
10.9
12.7
12.4
0.336
0.371
0.373
10.4
12.2
11.9
0.349
0.389
0.401
10.7
12.4
12.8
21
0.381
0.420
0.411
11.6
13.6
13.0
42
0.391
0.415
0.398
11.9
13.1
12.6
180
0.392
0.401
0.408
12.1
12.4
12.9
Days
Postpartum
2741
TABLE A-8 -- Estimation of Red Cell, Plasma, and Total Blood Volume in Adult Men and Women (12,13)
Men
Volume
Women
SD
(mL)
SD
(mL)
Red blood
cell volume
490
21.4
200
409
18.3
139
Plasma
volume
1050
19.6
260
455
28.9
213
Total blood
volume
1530
41.0
400
864
47.2
319
*Red cell volume measured by 51 Cr method. Plasma and blood volumes calculated from the red cell volume
and volume packed red cells without correction for trapped plasma or ``body hematocrit'' differences.
Instructions for use of table: For a subject of given weight (w, in kg), a normal mean red blood cell, plasma,
or total blood volume (V, in mL) can be calculated from the formula V=a+bw.
Example: In a 70-kg man, the mean red blood cell volume is 490+(21.470)+1988 mL2 SD;
range=1988400, or 1588 to 2388 mL. The expected normal range can be calculated from the formula
Range=mean2 SD.
Mean
95% Range
t59 Fe (minutes)
66
87.5
38-137
mg/day
35
32.2
13-50
mg/kg/day
10
0.56
0.46-0.75
mug/dL blood/day
31
0.69
0.41-0.97
55
83.9
68-100
mg/day
34
27.6
11-43
mg/kg/day
10
0.52
0.43-0.72
mug/dL blood/day
21
0.56
0.35-0.77
Red cell
59
Fe utilization
(%)
TABLE A-10 -- Reference Ranges* for Porphyrins and Porphyrin Precursors in Feces, Urine and
Erythrocytes (2)
Porphyrin or Precursor
Feces
Urine
Erythrocytes
Aminolevulinic acid
--
1.5-7.5 mg/24 hr
--
11.2-57.2 mumol/24 hr
TABLE A-10 -- Reference Ranges* for Porphyrins and Porphyrin Precursors in Feces, Urine and
Erythrocytes (2)
Porphyrin or Precursor
Feces
Urine
Erythrocytes
Porphobilinogen
--
<1 mg/24 hr
--
<4.4 mumol/24 hr
Uroporphyrin
0-0.06 mg/24 hr
10-30 mug/24 hr
Coproporphyrin
0-500 mug/24 hr
50-160 mug/24 hr
0-500 mug/24 hr
Protoporphyrin
0-600 mug/24 hr
--
0-60 mug/24 hr
Total porphyrin
4 mg/24 hr
<0.2 mg/24 hr
--
95% Limits
5-7.5
0.1-1.0
0.01-0.12
0.5-4.0
Urobilinogen, fecal
Ehrlich units/day
80-280
mg/day
40-200
2.6-5.0
0.5-5.0
60-270
<0.1
Unless otherwise indicated, values derived from Henry JB. Clinical diagnosis and management by
laboratory methods. 19th ed. Philadelphia: WB Saunders (2).
Sodium Chloride
(concentration in g/dL)
Before Incubation
After Incubation
0.85
0.75
0-5
0.65
0-10
0.60
0-40
Sodium Chloride
(concentration in g/dL)
Before Incubation
After Incubation
0.55
15-70
0.50
0-5
40-85
0.45
5-45
55-95
0.40
50-90
65-100
0.35
90-99
75-100
0.30
97-100
85-100
0.20
97-100
95-100
0.10
100
100
By permission of ASCP Press from Kjeldsberg C, Foucar K, McKenna R, et al. Practical diagnosis of
hematologic disorders. 2nd ed. Chicago: ASCP Press, 1995 (19).
2742
TABLE A-13 -- Automated Leukocyte Differential Counts, Reference Values in Normal Male Adults
Coulter S+STKR (80 Men)
Percentage
Mean
Central 95%
Range
Mean
Central 95%
Range
Lymphocytes
36.1
22.3-49.9
31.3
18.3-44.2
Monocytes
4.1
0.7-7.5
5.5
2.6-8.5
Granulocytes
59.7
45.5-74.0
--
--
Neutrophils
--
--
58.8
45.5-73.1
Eosinophils
--
--
1.9
0.0-4.4
Basophils
--
--
0.7
0.2-1.2
LUC
--
--
1.8
0.0-4.9
2.4
1.2-3.5
2.06
0.9-3.22
0.3
0.0-0.5
0.37
0.12-0.62
Granulocytes
(109 /L)
4.9
1.4-6.6
--
--
Neutrophils (109
/L)
--
--
4.01
1.31-6.71
Absolute Numbers
Lymphocytes
(109 /L)
Monocytes (10
/L)
TABLE A-13 -- Automated Leukocyte Differential Counts, Reference Values in Normal Male Adults
Coulter S+STKR (80 Men)
Percentage
Mean
Central 95%
Range
Mean
Central 95%
Range
Eosinophils (109
/L)
--
--
0.13
0.00-0.30
--
--
0.05
0.01-0.09
--
--
0.12
0.00-0.31
Data based on measurements from healthy male students, age range 23-31 years, at an altitude of 4500 ft.
LUC =large unstained cells.
Amount *
Granule Size
Staining Intensity
Background of
Cytoplasm
No staining
None
--
1+
50%
Small
Faint to moderate
Colorless to very
pale pink
2+
40-80
Small to medium
Moderate to strong
Colorless to pale
pink
3+
80-100
Medium to large
Strong
Colorless to pink
4+
100
Brilliant
Non visible
By permission of Williams & Wilkins from Kaplow LS. Cytochemistry of leukocyte alkaline phosphatase.
Am J Clin Pathol 1963; 39:439 (20).
*Percentage of volume of cytoplasm occupied by azo dye precipitate.
Number
Mean
95% Limits
Male
51
73
22-124
Female
50
91
33-149
Total
101
82
25-139
By permission of Grune & Stratton from Cartwright GE. Diagnostic laboratory hematology. 4th ed. New
York: Grune & Stratton, 1968 (9).
2743
TABLE A-16 -- Differential Counts of Bone Marrow Aspirates from 12 Healthy Men
Mean
(%)
Observed
Range
(%)
95%
Confidence
Limits (%)
53.6
49.2-65.0
33.6-73.6
Myeloblasts
0.9
0.2-1.5
0.1-1.7
Promyelocytes
3.3
2.1-4.1
1.9-4.7
Myelocytes
12.7
8.2-15.7
8.5-16.9
Metamyelocytes
15.9
9.6-24.6
7.1-24.7
Band
12.4
9.5-15.3
9.4-15.4
Segmented
7.4
6.0-12.0
3.8-11.0
3.1
1.2-5.3
1.1-5.2
Myelocytes
0.8
0.2-1.3
0.2-1.4
Metamyelocytes
1.2
0.4-2.2
0.2-2.2
Band
0.9
0.2-2.4
0-2.7
Segmented
0.5
0-1.3
0-1.1
0.1
0-0.2
--
25.6
18.4-33.8
15.0-36.2
Pronormoblasts
0.6
0.2-1.3
0.1-1.1
Basophilic
1.4
0.5-2.4
0.4-2.4
Polychromatophilic
21.6
17.9-29.2
13.1-30.1
Orthochromatic
2.0
0.4-4.6
0.3-3.7
Lymphocytes
16.2
11.1-23.2
8.6-23.8
Plasma cells
1.3
0.4-3.9
0-3.5
Monocytes
0.3
0-0.8
0-0.6
Megakaryocytes
0.1
0-0.4
--
Reticulum cells
0.3
0-0.9
0-0.8
M:E ratio
2.3
1.5-3.3
1.1-3.5
TABLE A-17 -- Red Blood Cell Values at Various Ages: Mean and Lower Limit of Normal (-2 SD)
Hemoglobin
(g/dL)
Age
Birth
(cord
blood)
Hematocrit
(%)
Red Cell
Count (1012
/L)
MCV (fl)
MCH (pg)
MCHC (g/dl)
13.5
51
42
4.7
3.9
108
98
34
31
33
30
1 to 3
18.5
days
(capillary)
14.5
56
45
5.3
4.0
108
95
34
31
33
29
1 week
17.5
13.5
54
42
5.1
3.9
107
88
34
28
33
28
2 weeks
16.5
12.5
51
39
4.9
3.6
105
86
34
28
33
28
1 month
14.0
10.0
43
31
4.2
3.0
104
85
34
28
33
29
2 months
11.5
9.0
35
28
3.8
2.7
96
77
30
26
33
29
3 to 6
months
11.5
9.5
35
29
3.8
3.1
91
74
30
25
33
30
0.5 to 2
years
12.0
0.5
36
33
4.5
3.7
78
70
27
23
33
30
2 to 6
years
12.5
11.5
37
34
4.6
3.9
81
75
27
24
34
31
6 to 12
years
13.5
11.5
40
35
4.6
4.0
86
77
29
25
34
31
Female
14.0
12.0
41
36
4.6
4.1
90
78
30
25
34
31
Male
14.5
13.0
43
37
4.9
4.5
88
78
30
25
34
31
Female
14.0
12.0
41
36
4.6
4.0
90
80
30
26
34
31
Male
15.5
13.5
47
41
5.2
4.5
90
80
30
26
34
31
12 to 18
years
18 to 49
years
From Dallman PR. In: Rudolph A, ed. Pediatrics. 16th ed., New York: Appleton-Century-Crofts, 1977 (21).
Lubin BH. Reference values in infancy and childhood. In: Nathan DG, Oski FA, eds. Hematology of
infancy and childhood. 4th ed. Philadelphia: WB Saunders, 1993 (22).
These data were compiled from several sources. Emphasis is on recent studies using electronic counters
and on the selection of populations that are likely to exclude individuals with iron deficiency. The mean2
SD can be expected to include 95% of the observations in a normal population.
MCV =mean corpuscular volume, MCH =mean corpuscular hemoglobin, MCHC =mean corpuscular
hemoglobin concentration.
2744
TABLE A-18 -- Full-term Infants: Normal Values of Hemoglobin, Hematocrit, Erythrocyte Count, Mean
Corpuscular Hemoglobin, Mean Corpuscular Volume, and Mean Corpuscular Hemoglobin Concentration
(22,23)
Age (Month)
0.5
(N=232)
1
(N=240)
2
(N=241)
4
(N=52)
6
(N=52)
9
(N=56)
12
(N=56)
16.60.11
13.90.10
11.20.06
12.20.14
12.60.10
12.70.09
12.70.09
13.4
10.7
9.4
10.3
11.1
11.4
11.3
530.4
440.3
350.2
380.4
360.3
360.3
370.3
41
33
28
32
31
32
33
RBC count
(meanSE)
(102 /L)
4.90.03
4.30.03
3.70.02
4.30.06
4.70.05
4.70.04
4.70.04
-2 SD+2 SD
3.9-5.9
3.3-5.3
3.1-4.3
3.5-5.1
3.9-5.5
4.0-5.3
4.1-5.3
MCH
(meanSE)
(pg)
33.60.1
32.50.1
30.40.1
28.60.2
26.80.2
27.30.2
26.80.2
30
29
27
25
24
25
24
105.30.6
101.30.3
94.80.3
86.70.8
76.30.6
77.70.5
77.70.5
88
91
84
76
68
70
71
3141.1
3181.2
3181.1
3272.7
3501.7
3491.6
3431.5
281
281
283
288
327
324
321
Hb
(meanSE)
(g/dL)
-2 SD
Hct
(meanSE)
(%)
-2 SD
-2 SD
MCV
(meanSE)
(fL)
-2 SD
MCHC
(meanSE)
(g/L)
-2 SD
These values were obtained from a selected group of 256 healthy term infants followed at the Helsinki
University Central Hospital who were receiving continuous iron supplementation and who had normal
values for transferrin saturation and serum ferritin.
Values at the ages of 0.5, 1, and 2 months were obtained from the entire group, and those at the later ages
from the iron-supplemented infant group after exclusion of iron deficiency.
TABLE A-19 -- Leukocyte Counts and Differential Counts Reference Values in Children
Total
Leukocytes
Age
Neutrophils
Lymphocytes
%
Mean (Range)
Monocytes
%
Mean
Eosinophils
Mean
Birth
18.1
(9.030.0)
11.0
(6.026.0)
61
5.5
(2.011.0)
31
1.1
0.4
12
hours
22.8
(13.038.0)
15.5
(6.028.0)
68
5.5
(2.011.0)
24
1.2
0.5
24
hours
18.9
(9.434.0)
11.5
(5.021.0)
61
5.8
(2.011.5)
31
1.1
0.5
1 week 12.2
(5.021.0)
5.5
(1.510.0)
45
5.0
(2.017.0)
41
1.1
0.5
2
weeks
11.4
(5.020.0)
4.5
(1.0-9.5) 40
5.5
(2.017.0)
48
1.0
0.4
1
10.8
month
(5.019.5)
3.8
(1.0-9.0) 35
6.0
(2.516.5)
56
0.7
0.3
6
11.9
months
(6.017.5)
3.8
(1.0-8.5) 32
7.3
(4.013.5)
61
0.6
0.3
1 year
11.4
(6.017.5)
3.5
(1.5-8.5) 31
7.0
(4.010.5)
61
0.6
0.3
2 years 10.6
(6.017.0)
3.5
(1.5-8.5) 33
6.3
(3.0-9.5) 59
0.5
0.3
4 years 9.1
(5.515.5)
3.8
(1.5-8.5) 42
4.5
(2.0-8.0) 50
0.5
0.3
6 years 8.5
(5.014.5)
4.3
(1.5-8.0) 51
3.5
(1.5-7.0) 42
0.4
0.2
8 years 8.3
(4.513.5)
4.4
(1.5-8.0) 53
3.3
(1.5-6.8) 39
0.4
0.2
10
years
8.1
(4.513.5)
4.4
(1.8-8.0) 54
3.1
(1.5-6.5) 38
0.4
0.2
16
years
7.8
(4.513.0)
4.4
(1.8-8.0) 57
2.8
(1.2-5.2) 35
0.4
0.2
21
years
7.4
(4.511.0)
4.4
(1.8-7.7) 59
2.5
(1.0-4.8) 34
0.3
0.2
Numbers of leukocytes are in thousands per mm3 , ranges are estimates of 95% confidence limits, and
percentages refer to differential counts. Neutrophils include band cells at all ages and a small number of
metamyelocytes and myelocytes in the first few days of life.
From Dallman PR. In: Rudolph AM, ed. Pediatrics. 16th ed. New York: Appleton-Century-Crofts, 1977
(21). Lubin BH. Reference values in infancy and childhood. In: Nathan DG, Oski FA, eds. Hematology of
infancy and childhood. 4th ed. Philadelphia: WB Saunders, 1993 (22).
2745
Cell Type
1 (n=71)
2 (n=48)
3 (n=24)
4 (n=19)
5 (n=22)
6 (n=22)
9 (n=16)
12 (n=18)
15 (n=12)
18 (n=1
all
phocytes
14.425.54 47.059.24 42.687.90 43.6311.83 47.068.77 47.199.93 47.557.88 48.768.11 47.1111.32 42.778.94 43.558
nsitional
s
1.181.13
1.950.94
2.381.35
2.171.64
1.641.01
1.830.89
2.311.16
1.921.39
2.321.90
1.700.82
1.991.0
erythroblasts 0.020.06
0.100.14
0.130.19
0.100.13
0.050.10
0.070.10
0.090.12
0.070.09
0.020.04
0.070.12
0.080.1
ophilic
hroblasts
0.240.25
0.350.33
.570.41
0.400.33
0.240.24
0.470.33
0.320.24
0.310.24
0.300.25
0.380.37
0.500.3
ly
hroblasts
0.270.26
0.440.42
0.710.51
0.500.38
0.280.30
0.550.36
0.410.30
0.390.28
0.390.27
0.460.36
0.590.3
ychromatic
hroblasts
13.066.78 6.904.45
13.063.48 10.513.39
6.842.58
7.552.35
7.303.60
7.733.39
6.833.75
6.041.56
6.973.5
hochromatic 0.690.73
hroblasts
0.541.88
0.660.82
0.700.87
0.340.30
0.460.51
0.380.56
0.390.48
0.370.51
0.500.65
0.440.4
0.160.17
0.260.22
0.190.12
0.160.17
0.140.11
0.160.22
0.220.25
0.230.25
0.170.12
0.210.1
e
hroblasts
14.227.14 7.604.84
13.993.82 11.403.43
7.342.54
8.162.58
7.854.11
8.343.31
7.424.11
6.721.80
7.623.6
ly/late
hroblasts
1:50
1:18
1:23
1:15
1:17
1:19
1:17
1:15
1:10
1:15
1:22
al
hroblasts
14.487.24 8.045.00
14.703.86 11.903.52
7.622.56
8.702.69
8.254.31
8.723.34
7.814.26
7.181.95
8.2137
od
culocytes
4.181.46
1.061.13
3.391.22
2.900.91
1.650.73
1.380.65
1.740.80
1.670.52
1.790.79
2.100.91
1.840.4
myelocytes
0.790.91
0.760.65
0.780.68
0.760.80
0.590.51
0.870.80
0.670.66
0.410.34
0.690.71
0.670.58
0.640.5
elocytes
3.952.93
2.501.48
2.031.14
2.241.70
2.321.59
2.731.82
2.221.25
2.071.20
2.321.14
2.480.94
2.491.3
ly
trophils
4.743.43
3.271.94
2.811.62
3.002.18
2.912.01
3.602.50
2.891.71
2.481.46
3.021.52
3.161.19
3.141.7
utrophils
12.487.45 12.424
ds
15.174.20 14.205
ure
trophils
7.374.64
4.272.69
6.943.88
3.642.97
3.072.45
3.481.62
3.772.44
4.852.69
3.972.29
5.653.92
6.313.9
e neutrophils 55.637.98 29.086.79 27.506.88 31.0011.17 31.307.80 29.737.19 29.866.74 29.867.36 30.778.69
34.607.35 32.937
ly/late
trophil ratio
1:10
1:12
1:9
1:9
1:9
1:11
1:8
1:10
1:12
1:10
1:10
Cell Type
0 (n=57) *
1 (n=71)
2 (n=48)
3 (n=24)
4 (n=19)
5 (n=22)
6 (n=22)
9 (n=16)
12 (n=18)
15 (n=12)
18 (n=1
al
trophils
37.767.32 36.067
al
nophils
2.701.27
2.611.40
2.501.22
2.541.46
2.374.13
1.980.86
2.081.16
1.741.08
1.921.09
3.391.93
2.702.1
al basophils
0.120.20
0.070.16
0.080.10
.090.09
0.110.14
0.940.13
0.100.13
0.110.13
0.130.15
0.270.37
0.100.1
al myeloid
s
41.427.43 38.867
nocytes
0.880.85
1.010.89
0.910.83
0.680.56
0.750.75
1.291.06
1.211.01
1.170.97
1.461.52
1.681.09
2.121.5
gakaryocytes 0.060.15
0.050.09
0.100.13
0.060.09
0.060.06
0.080.09
0.040.07
0.090.12
0.050.08
0.000.00
0.070.1
sma cells
0.000.02
0.020.06
0.020.05
0.000.02
0.010.03
0.050.11
0.030.07
0.010.03
0.030.07
0.070.12
0.060.0
0.620.50
0.580.50
0.630.60
0.560.53
0.500.37
0.560.48
0.420.50
0.370.33
0.460.32
0.430.4
known cells
0.220.34
0.210.25
0.160.24
0.190.21
0.230.25
0.170.22
0.100.15
0.140.17
0.110.14
0.130.18
0.200.2
maged cells
5.792.78
5.502.46
5.091.78
4.752.30
4.802.29
4.861.25
5.041.08
4.891.60
5.342.19
4.991.96
5.052.1
al
6.382.84
6.392.63
5.941.94
5.632.36
5.662.30
5.661.41
5.781.16
5.551.74
5.902.03
5.652.02
5.812.1
cellaneous
Percentages of cell types (meansstandard deviation) in tibial bone marrow of infants from birth to 18 months of age. Data obtained from normal American
fants of black, white, and Asian racial origin. The changes in the marrow during the first 18 months of postnatal life are based on differential counts of 1,0
ls classified on stained smears on each of 10 serial marrow samples aspirated from the same population of infants. Criteria for including bone marrow data
this study consisted of absence of any clinical evidence of disease, normal rate of growth, and normal serum proteins and transferrin saturations.
Expressed in round figures for facilitating comparison. MeansSD were calculated from values obtained in individual infants, and statistical comparison
were performed.
*n, number of infants studied at each stage.
2746
Mean
Plasma iron
mug/dL
mumol/L
122
71(43-112)
201(112-276)
109
60(28-101)
173(130-202)
21.8
12.7(7.7-20.0)
35.9(20.0-49.3)
Mean
19.5
107(5.0-18.0)
30.9(23.2-36.1)
340
250(224-306)
400(429-472)
mumol/L
60.7
44.8(40.0-54.6)
71.6(66.6-84.3)
35
20
55
mug/dL
114
70
155
mumol/L
18.1
11
24
Plasma copper
TABLE A-22 -- Serum Folate, Vitamin B12 , and Related Determinations (2,28)
Measurement
Mean
Lower Limit
of Normal *
450
160(100-270)
950(750-1200)
8.1
5(2.3-7.5)
25(9-28)
Erythrocyte folate
(mug/L)
274
166(50-325)
640(300-875)
Urinary methylmalonate
(mg/day)
--
--
Urinary
formiminoglutamate
(FIGIu) (mg/day)
--
0.1
TABLE A-23 -- Vitamin B12 Absorption by the Urinary Excretion Method (Schilling Test) (23)
Urinary Vitamin B12 Excretion (%)
Oral Vitamin B12 Dose (mug)
24 hr *
48 hr *
0.5
26(16-40)
37(21-48)
1.0
22(11-39)
29(14-46)
TABLE A-23 -- Vitamin B12 Absorption by the Urinary Excretion Method (Schilling Test) (23)
Urinary Vitamin B12 Excretion (%)
Oral Vitamin B12 Dose (mug)
2.0
24 hr *
11(5-17)
48 hr *
17(11-34)
*With 24-hour collections, one injection of 1000 mug ``cold'' B12 was administered; with 48-hour
collections, two injections of 1000 mug ``cold'' B12 were administered at 24-hour intervals.
Enzyme Activity
(IU/g hemoglobin)
Acetylcholinesterase
36.93.83
Adenosine deaminase
1.110.23
Adenylate kinase
25829.3
Bisphosphoglyceromutase
(2,3,-diphosphoglyceromutase)
4.780.65
Catalase
Fructose-bisphosphate aldolase
(aldolase)
Galactokinase
15.32.39104
3.190.86
0.0790.006
0.0290.006
Galactose-1-phosphate uridylyl-tranferase
28.46.94
Glucose-6-phosphate dehydrogenase
8.341.59
60.811.0
gamma-Glutamyl-cysteine synthetase
0.430.04
31.42.97
7.181.09
Glutathione synthetase
0.190.03
Hexokinase
1.160.17
Hypoxanthine phosphoribosyltransferase
(hypoxanthine guanosine-phosphoribosyltransferase)
1.720.3
Methemoglobin reductase
2.600.71
6-Phosphofructokinase
11.02.33
Phosphogluconate dehydrogenase
(decarboxylating)
8.780.78
Enzymes (Synonym)
Phosphoglycerate kinase
32036.1
Pyrimidine 5`-nucleotidase
0.110.03
Pyruvate kinase
15.01.96
Triosephosphate isomerase
2111397
Uroporphyrinogen I synthase
2.52
From Beutler E, Blume KG. Human erythrocytes, enzymes, and intermediate metabolites related to clinical
disorders. In: Altman PL, Dittmer DS, eds. Human health and disease. vol. II, Bethesda: Federation of
American Societies for Experimental Biology, 1977 (26).
Lubin BH. Reference values in infancy and childhood. In: Nathan DG, Oski FA, eds. Hematology of
infancy and childhood. 4th ed. Philadelphia: WB Saunders, 1993 (22).
2747
Age
% of
No. of
Adult
Subjects mg/dL (range) Level
Level of gammaM
*
mg/dL
(range)
115(530)
Level of gammaA *
% of
Adult
Level
mg/dL
(range)
% of
% of
Adult
Adult
Level mg/dL (range) Level
115
23(0-11)
12
1044201(660- 6713
1439)
Newborn
22
1031200(645- 8917
1244)
1-3 mo
29
430119(272762)
2113(656)
117
481127(324699)
319
4-6 mo
33
427186(2061125)
2818(893)
149
498204(2281232)
3213
7-12 mo
56
661219(2791533)
3718(1698)
199
752242(3271687)
4815
13-24 mo
59
762209(2581393)
5024(19112)
2512
870258(3981586)
5616
25-36 mo
33
892183(4191274)
7137(19235)
3-5 yr
28
929228(5691597)
9327(55152)
6-8 yr
18
923256(5591492)
9-11 yr
Age
% of
No. of
Adult
Subjects mg/dL (range) Level
Level of gammaM
*
mg/dL
(range)
% of
Adult
Level
Level of gammaA *
mg/dL
(range)
% of
% of
Adult
Adult
Level mg/dL (range) Level
12-16 yr
946124(7261085)
Adults
30
By permission from Stiehm ER, Fudenberg HH. Serum levels of immune globulins in health and disease. Pediatrics
1966 37:715 (29).
*Mean is 1 SD.
2748
TABLE A-26 -- Reference Values for Tests of Hemostasis and Blood Coagulation
Normal Range
(2 SD)
Test
Bleeding time
Ivy
1-9 min *
Duke
1-5 min
68-82 sec
Activated
32-46 sec
11-15 sec
8-18 min
10-16 sec
Fibrinogen assay
150-350 mg/dL
>2 hours
>8 mug/dl
neg. 24 hr
Plasminogen activity
74-124%
TABLE A-26 -- Reference Values for Tests of Hemostasis and Blood Coagulation
Normal Range
(2 SD)
Test
Antithrombin III
85-122%
27-35 mg/dL
Protein C
60-150%
Protein S
66-122%
Ritocetin factor
0.5-1.6 U/mL
43-150%
60-146%
50-150% of normal
References
1. Lee
GR, Bitnell TC, Foerester J, et al. Wintrobe's clinical hematology. 9th ed. Philadelphia: Lea and
Febiger, 1993.
2. Henry
JB. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: WB
Saunders, 1996.
3. Beutler
E, Lichtman MA, Coller BS, Kipps TJ. William's hematology. 5th ed. New York: McGraw-Hill,
1995.
4. Wintrobe
5. Greendyke
RM, Meriwether WA, Thomas ET, et al. A suggested revision of normal values for
hemoglobin, hematocrit, and erythroid count in healthy adult men. Am J Clin Pathol 1962;37:429-436.
6. von
P, Humbert JC, Mahassen P, et al. Reticulocytes: biological variations and reference limits. Eur J
Haematol 1994;53:11-15.
8. Miller
A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. BMJ
1983;286:266-271.
9. Cartwright
GE. Diagnostic Laboratory Hematology. 4th ed. New York: Grune and Stratton, 1968.
10. Stroop
DM, Triplett RC, Perrotta G, et al. Comparison of the Abbott cell DYN 3000 SL and the Coulter
STKS hematology analyzers. Ann Clin Lab Sci 1994;24:250-258.
11. deLeeuw
NKM, Lowenstein L, Hsieh YS. Iron deficiency and hydremia in normal pregnancy. Medicine
1996;45:291-315.
12. Brown
E, Hopper J, Hodges JL, et al. Red cell, plasma, and blood volume in healthy women measured
by radiochromium cell-labeling and hematocrit. J Clin Invest 1962;;41:2182-2190.
13. Wennesland
R, Brown E, Hopper J, et al. Red cell, plasma, and blood volume in healthy men measured
by radiochromium (Cr51 ) cell tagging and hematocrit: influence of age, somatotype and habits of physical
activity on the variance after regression volumes to height and weight combined. J Clin Invest
1959;38:1065-1077.
14. Bohanan
RA, Hutchison JL, Townsend SR. The use of radioiron in the study of anemia. Ann Intern Med
1961;55:975-988.
15. Bush
JA, Ashenbrucker H, Cartwright GE, Wintrobe ME. The anemia of infection. xx. The kinetics of
iron metolism in the anemia associated with chronic infection. J Clin Invest 1956;35:89-97.
16. Giblett
ER, Coleman DH, Pirzio-Biroli G, et al. Erythrokinetics: quantitative measurements of red cell
production and destruction in normal subjects and patients with anemia. Blood 1956;11:291-309.
17. Hosain
F, Marsaglia G, Finch CA. Blood ferrokinetics in normal man. J Clin Invest 1967;46:1-9.
18. Berk
PD, Howe RB, Bloomer JR, Berlin NI. Studies of bilirubin inetics in normal adults. J Clin Invest
1969;48:2176-2190.
19. Kjeldsberg
21. Mentzer
WC. Blood and blood-forming tissues. In: Rudolph AM, Hoffman JIE, Rudolph CD, eds.
Rudolph's pediatrics. 20th ed. Stamford: Appleton and Lange, 1996.
22. Lubin
BH. Reference values in infancy and childhood. In: Hematology of infancy and childhood. In:
Nathan DG, Oski FA, eds. Hematology of infancy and childhood. 4th ed. Philadelphia: WB Saunders,
1993;i-xix.
23. Saarien
UM, Siimes MA. Developmental changes in red blood cell counts and indices of infants after
exclusion of iron deficiency by laboratory criteria and continuous iron supplementation. J Pediatr
1978;92:414-416.
24. Rosse
C, Kraemer MJ, Dillon TL, et al. Bone marrow cell populations of normal infants: the
predominance of lymphocytes. J Clin Lab Med 1977;89:1225-1240.
25. Beale
RN, Bostrom JO, Taylor RF. Improved rapid methods for the determination of iron content and
binding capacity of serum. J Clin Pathol 1962;15:156-160.
26. Beutler
E, Blume KG. Human erythrocytes, enzymes and intermediate metabolites related to clinical
disorders. In: Altman PL, Dittmer-Katz DS, eds. Human health and disease. Bethesda: Federation of
American Societies for Experimental Biology, 1977.
27. Ramsay
28. Chanarin
29. Stiehm
I. The megaloblastic anemias. 3rd ed. Chicago: Year Book Medical Publishers, 1990.
ER, Fudenberg HH. Serum levels of immune globulins in health and disease. Pediatrics
1966;37:715-725.